1-2 of 2
Giulia De Riso, RN
Close
Save search
Sort by
Journal Articles

Imatinib Suspension and Validation (ISAV) Study: Results at 24 Months

Free
Silvia Mori, PhD, Philipp le Coutre, MD, Elisabetta Abruzzese, MD, Bruno Martino, MD, Ester Pungolino, MD, Chiara Elena, MD, Ivana Pierri, MD, Sarit E. Assouline, MDMSc, Anna D'Emilio, MD, Antonella Gozzini, MD, Pilar Giraldo, MD PhD, Fabio Stagno, MD PhD, Alessandra Iurlo, MD PhD, Andrea Aroldi, MD, Michela Luciani, RN, Giulia De Riso, RN, Kim Dong-Wook, MD PhD, Alessandra Pirola, MSc, Anna Petroccione, Maria Luisa Bonanomi, Patrizia Crivori, PhD, Rocco Piazza, MDPhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2015) 126 (23): 2775.
https://doi.org/10.1182/blood.V126.23.2775.2775
Published: 2015
Journal Articles

The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis

Free
Silvia Mori, PhD, Elisabetta Vagge, MD, Philipp le Coutre, MD, Elisabetta Abruzzese, MD, Bruno Martino, MD, Ester Pungolino, MD, Chiara Elena, MD, Ivana Pierri, MD, Sarit Assouline, MD MSc, Anna D'Emilio, MD, Antonella Gozzini, MD, Pilar Giraldo, MD PhD, Fabio Stagno, MD PhD, Alessandra Iurlo, MD PhD, Michela Luciani, RN, Giulia De Riso, RN, Kim Dong-Wook, MD PhD, Alessandra Pirola, M.Sc., Anna Petroccione, Agnese Lodolo D'Oria, Patrizia Crivori, PhD, Rocco Piazza, MD PhD, Carlo Gambacorti-Passerini, MD
Journal: Blood
Blood (2014) 124 (21): 813.
https://doi.org/10.1182/blood.V124.21.813.813
Published: 2014